Rheumatoid arthritis, also known as RA, is a chronic systemic inflammatory disease whose etiology hasn’t been specified. It belongs to the autoimmune inflammatory disease category, featuring in chronic, symmetric, polysynovial arthritis and the external lesion […]
Biologics have changed the landscape of therapy for rheumatoid arthritis (RA). While they have substantially improved outcomes in patients with RA who are disease-modifying antirheumatic drug (DMARD) incomplete responders (IRs), they require administration via […]
Recently, a biotechnology company announced that gerilizumab IL-6 as a drug for rheumatoid arthritis was under trial in healthy people. Once the safety is proved in human trial, gerilizumab will […]